{"id":141590,"date":"2024-12-27T15:37:35","date_gmt":"2024-12-27T10:07:35","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=141590"},"modified":"2024-12-27T15:37:38","modified_gmt":"2024-12-27T10:07:38","slug":"pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/","title":{"rendered":"Pharma stock jumps 8% after Sunil Singhania\u2019s Abakkus AMC acquires \u20b961 Cr worth of stake"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3591917527\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>In Friday\u2019s trading session, the shares of one of the pharma stocks specialising in development, manufacturing, and commercialization of a wide range of Active Pharmaceutical Ingredients (APIs) and intermediates jumped by 8 percent after Ace investor Sunil Singhania buys stake in it worth ~Rs. 62 crores<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-970386602\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Price action<\/strong><\/h2><p>With a market capitalization of 5,725.3 Crores on Friday, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/AARTIPHARM\" target=\"_blank\" rel=\"noreferrer noopener\">Aarti Pharmalabs Limited<\/a> <\/strong>rose by 7.6 percent making a high of Rs 714.25 compared to its previous closing price of Rs 631.75.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>What Happened<\/strong><\/h2><p>Aarti Pharmalabs Limited specializes in the development, manufacturing, and commercialization of a wide range of Active Pharmaceutical Ingredients (APIs) and intermediates.<\/p><p>Ace investor Sunil Singhania\u2019s Abakkus Asset Management has purchased a significant stake in the company via a block deal. On December 26, Abakkus Asset Management acquired 10,69,972 shares of Aarti Pharmalabs, representing a 1.18 percent stake in the company. The shares were acquired at an average price of Rs. 575.04 per share, bringing the total deal value to Rs. 61.52 crore.<\/p><div class=\"trade-content_5\" id=\"trade-1653456502\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>The company\u2019s promoter group entities, Orchid Family Trust and Tulip Family Trust, were the sellers. Orchid Family Trust offloaded 4,97,750 shares, representing 0.54 percent of the company, while Tulip Family Trust sold 5,02,250 shares, or 0.55 percent, at Rs. 575 per share.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>About the company<\/strong><\/h2><p>Aarti Pharmalabs Ltd. is a leading Indian pharmaceutical company that offers a comprehensive portfolio of products catering to various therapeutic segments, including cardiovascular, anti-diabetic, anti-inflammatory, and central nervous system disorders.<\/p><p>The company is known for its expertise in providing high-quality, cost-effective solutions to the global pharmaceutical industry. It also focuses on contract research and manufacturing services (CRAMS), collaborating with multinational pharmaceutical companies.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Future outlook<\/strong><\/h2><p>Aarti Pharmalabs Ltd plans to strengthen its API and CDMO (Contract Development and Manufacturing Organization) segments by introducing more value-added products and acquiring new customers. The company expects an EBITDA growth of approximately 10-12 percent in FY25 and aims to achieve a long-term annual growth rate of about 15 percent over the next three years.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Financials&nbsp;<\/strong><\/h2><p>The company&#8217;s revenue rose by 5&nbsp; percent from Rs 440.78 crore to Rs 462.51 crore in Q2FY24-25. Meanwhile, Net profit inclined from Rs 51.8 crores to Rs 54.62 crore during the same period.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Key Financial ratios<\/strong><\/h2><p>Aarti Pharmalabs Limited&nbsp; has an Return on Equity&nbsp; (RoE)&nbsp; of 12.28&nbsp; percent and a Return on Capital Employed&nbsp; (RoCE) of 14.91 percent.&nbsp; Furthermore, the company&#8217;s debt-to-equity ratio is 0.21.<\/p><div class=\"trade-content-10\" id=\"trade-1401740410\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Sridhar J<\/strong><\/p><\/blockquote><\/blockquote><\/blockquote><\/blockquote><h2 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h2><div class=\"wp-block-image\"><figure class=\"aligncenter\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on&nbsp;<a href=\"https:\/\/tradebrains.in\/\">tradebrains.in<\/a>&nbsp;are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-3540013588\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>In Friday\u2019s trading session, the shares of one of the pharma stocks specialising in development, manufacturing, and commercialization of a wide range of Active Pharmaceutical Ingredients (APIs) and intermediates jumped by 8 percent after Ace investor Sunil Singhania buys stake in it worth ~Rs. 62 crores Price action With a market capitalization of 5,725.3 Crores [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[25930,25932,15654,948,936,25933],"class_list":["post-141590","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-aarti-pharmalabs-limited","tag-aarti-pharmalabs-limited-latest-stake-acquisition","tag-pharma-stock-news","tag-stock-market","tag-stock-market-news","tag-sunil-singhanias-abakkus-asset-management-acquires-61-cr-worth-stake"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock jumps 8% after Sunil Singhania\u2019s Abakkus AMC acquires \u20b961 Cr worth of stake - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"In Friday\u2019s trading session, the shares of one of the pharma stocks specialising in development, manufacturing, and commercialization of a wide range of Active Pharmaceutical Ingredients (APIs) and intermediates jumped by 8 percent after Ace investor Sunil Singhania buys stake in it worth ~Rs. 62 crores\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock jumps 8% after Sunil Singhania\u2019s Abakkus AMC acquires \u20b961 Cr worth of stake\" \/>\n<meta property=\"og:description\" content=\"In Friday\u2019s trading session, the shares of one of the pharma stocks specialising in development, manufacturing, and commercialization of a wide range of Active Pharmaceutical Ingredients (APIs) and intermediates jumped by 8 percent after Ace investor Sunil Singhania buys stake in it worth ~Rs. 62 crores\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-27T10:07:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-27T10:07:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/\",\"name\":\"Pharma stock jumps 8% after Sunil Singhania\u2019s Abakkus AMC acquires \u20b961 Cr worth of stake - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-12-27T10:07:35+00:00\",\"dateModified\":\"2024-12-27T10:07:38+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"In Friday\u2019s trading session, the shares of one of the pharma stocks specialising in development, manufacturing, and commercialization of a wide range of Active Pharmaceutical Ingredients (APIs) and intermediates jumped by 8 percent after Ace investor Sunil Singhania buys stake in it worth ~Rs. 62 crores\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock jumps 8% after Sunil Singhania\u2019s Abakkus AMC acquires \u20b961 Cr worth of stake\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock jumps 8% after Sunil Singhania\u2019s Abakkus AMC acquires \u20b961 Cr worth of stake - Trade Brains Features","description":"In Friday\u2019s trading session, the shares of one of the pharma stocks specialising in development, manufacturing, and commercialization of a wide range of Active Pharmaceutical Ingredients (APIs) and intermediates jumped by 8 percent after Ace investor Sunil Singhania buys stake in it worth ~Rs. 62 crores","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock jumps 8% after Sunil Singhania\u2019s Abakkus AMC acquires \u20b961 Cr worth of stake","og_description":"In Friday\u2019s trading session, the shares of one of the pharma stocks specialising in development, manufacturing, and commercialization of a wide range of Active Pharmaceutical Ingredients (APIs) and intermediates jumped by 8 percent after Ace investor Sunil Singhania buys stake in it worth ~Rs. 62 crores","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-12-27T10:07:35+00:00","article_modified_time":"2024-12-27T10:07:38+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/","name":"Pharma stock jumps 8% after Sunil Singhania\u2019s Abakkus AMC acquires \u20b961 Cr worth of stake - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-12-27T10:07:35+00:00","dateModified":"2024-12-27T10:07:38+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"In Friday\u2019s trading session, the shares of one of the pharma stocks specialising in development, manufacturing, and commercialization of a wide range of Active Pharmaceutical Ingredients (APIs) and intermediates jumped by 8 percent after Ace investor Sunil Singhania buys stake in it worth ~Rs. 62 crores","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-jumps-8-after-sunil-singhanias-abakkus-amc-acquires-61-cr-worth-of-stake\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock jumps 8% after Sunil Singhania\u2019s Abakkus AMC acquires \u20b961 Cr worth of stake"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=141590"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141590\/revisions"}],"predecessor-version":[{"id":141591,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/141590\/revisions\/141591"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=141590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=141590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=141590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}